TM FLOW SYSTEM VASCULAR FUNCTION AND AUTONOMIC NERVOUS SYSTEM ASSESSMENTS VASCULAR FUNCTION AND AUTONOMIC NERVOUS SYSTEM ASSESSMENTS 3 TECHNOLOGIES 3 TECHNOLOGIES TBL-ABI SWEATC OXI_W TM FLOW INTENDED USE: Measurement of Ankle Brachial Indices for the screening of Peripheral Artery Disease. Measurement of Ankle Brachial Indices for the screening of Peripheral Artery Disease. Measurement of the Galvanic Skin response related to the sudomotor function. Mathematical Analysis of the Photoplethysmography for assessing: - The autonomic nervous system via Heart Rate Variability Analysis at rest and during the Ewing Tests. - The Endothelial function via the Photoplethysmography (PTG) Analysis. Play Video TM-FLOW ASSESMENTS BLOOD PRESSURE AND ARTERIAL STIFFNESS ANALYSIS Monitoring and treatment.Management of hypertension PHOTOPLETHYSMOGRAPHY Mathematical Analysis of the pulse Ox wave ANKLE BRAKIAL INDEX (ABI) Peripheral Artery Disease (PAD). Blood flow blockage or calcification HEART RATE VARIABILITY (HRV) Cardiac Autonomic Dysfunction Assessment CARDIAC AUTOMATIC REFLEX TESTs (CARTs) Cardiac Autonomic Neuropathy assessment SUDOMOTOR FUNCTION TESTS Skin Microcirculation and small fiber Assessments TM-FLOW ASSESMENTS MAIN SYMPTOMS OF AUTONOMIC NEUROPATHY AND VASCULAR DYSFUNCTION MAIN SYMPTOMS OF AUTONOMIC NEUROPATHY AND VASCULAR DYSFUNCTION FATIGUE HEADACHE DIZZINESS EXERCISE INTOLERANCE PAINFUL MUSCLE CRAMPING FAINTING TINGLING IN THE TOES OR FINGERS CLAUDICATION THIGHS OR CALVES WHEN WALKING CLIMBING STAIRS OR EXERCING USA POPULATION THAT SHOULD BE TESTED BY LD TECHNOLOGY PRODUCTS 50+ Population over 50 years oldwith cardiovascular risk factors(Hypertensive, Overweight, Smoker, Diabetic) 70+ Population over 70 years old. USA POPULATION THAT SHOULD BE TESTED BY LD TECHNOLOGY PRODUCTS USA POPULATION THAT SHOULD BE TESTED BY LD TECHNOLOGY PRODUCTS 50+ Population over 50 years oldwith cardiovascular risk factors(Hypertensive, Overweight, Smoker, Diabetic) 70+ Population over 70 years old. EVERYONE IN THE RISK GROUP SHOULD BE MEASURED WITH TM-FLOW SYSTEM. EVERYONE IN THE RISK GROUP SHOULD BE MEASURED WITHTM-FLOW SYSTEM. MAIN MARKERS VASCULAR FUNCTION ASSESSMENT VASCULAR FUNCTION ASSESSMENT Arterial stiffness and Ankle Brachial Indices from the Volume plethysmography analysis. Endothelial FunctionPatented markers from mathematical analysis of the photoplethysmography spectral analysis. (Off label use). AUTONOMIC NERVOUS SYSTEM ASSESSMENT AUTONOMIC NERVOUS SYSTEM ASSESSMENT Sudomotor Function Markers. Heart rate variability Analysis (HRV). Cardiac Autonomic Reflex Tests: - Valsalva Ratio, - E/I Ratio , - K30/15 Ratio and - Systolic Pressure Response to Standing. CLINICAL VALIDATION PTG Spectral Analysis Markers to:- The gold standard of Insulin resistance assessment.- The Coronary angiography.- Vascular blood tests (CRP and fibrinogen). Sudomotor markers to the:- Small fiber Neuropathy Symptoms.- Microvascular disease (retinopathy). Cardiometabolic Score to the Oral Glucose Tolerance Test (OGTT). See results in page Clinical Studies TM FLOW HARDWARE COMPONENTS This video animation shows you the full components of the TM FLOW system.It will help the user to properly setup the hardware and how to charge the wireless devices. PATIENT SETUP TM FLOW BROCHURE DOWNLOAD